Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813 · cited 1×
“Given the high incidence of IFD in AML/MDS patients, antifungal prophylaxis with a mould-active azole such as posaconazole seems justifiable [30].”
BackgroundKontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456 · cited 4×
“3% for all mould infections [19], and an Italian retrospective study reported only three cases of fusariosis among 1249 allogeneic HCT recipients (0.”
BackgroundResultInfluentialEpidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448 · cited 2×
“The time of occurrence of IFD in the present study showed a typical pattern in which most cases were diagnosed during the period of neutropenia of induction chemotherapy in the AML/MDS cohort and in autologous HCT recipients, and was distributed throughout the post-transplant period in allogeneic HCT, as previously re…”
ResultMarr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957 · cited 2×
“The time of occurrence of IFD in the present study showed a typical pattern in which most cases were diagnosed during the period of neutropenia of induction chemotherapy in the AML/MDS cohort and in autologous HCT recipients, and was distributed throughout the post-transplant period in allogeneic HCT, as previously re…”
Result(2006) · PubMed · Cited by 906
Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis
Kim, H. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1210 · Cited by 507 · cited 1×
“The incidence of IFD in the present study was expressed as CI with competing events because this is an appropriate measure of incidence in a cohort with different durations of observation and various competing risks [24].”
BackgroundFukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood · doi:10.1182/blood-2003-02-0456 · Cited by 465 · cited 1×
“The incidence and epidemiology of such infections have been characterized in various retrospective studies [3–17] and a few prospective studies [18–22] conducted in Europe, the USA and Japan.”
ResultPagano, L., Caira, M., Nosari, A., Van Lint, M. T., Candoni, A., Offidani, M., Aloisi, T., Irrera, G., Bonini, A., Picardi, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522189 · Cited by 414 · cited 4×
“[16].”
ResultInfluentialGarcia‐Vidal, C., Upton, A., Kirby, K. A., & Marr, K. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591969 · Cited by 364 · cited 1×
“The incidence and epidemiology of such infections have been characterized in various retrospective studies [3–17] and a few prospective studies [18–22] conducted in Europe, the USA and Japan.”
Result
Cited by
Tortorano, A. M., Richardson, M., Roilides, E., van Diepeningen, A., Caira, M., Munoz, P., Johnson, E., Meletiadis, J., Pana, Z.-D., Lackner, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12465 · Cited by 523
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
The global burden of fungal diseases
Vallabhaneni, S., Mody, R. K., Walker, T., & Chiller, T. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.004 · Cited by 292
An overview of infectious complications after allogeneic hematopoietic stem cell transplantation
Sahin, U., Toprak, S. K., Atilla, P. A., Atilla, E., & Demirer, T. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.05.006 · Cited by 252
Colombo, A. L., de Almeida Júnior, J. N., Slavin, M. A., Chen, S. C.-A., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 173
Self-citationPagano, L., Busca, A., Candoni, A., Cattaneo, C., Cesaro, S., Fanci, R., Nadali, G., Potenza, L., Russo, D., Tumbarello, M., et al. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.09.002 · Cited by 148
Koehler, P., Hamprecht, A., Bader, O., Bekeredjian-Ding, I., Buchheidt, D., Doelken, G., Elias, J., Haase, G., Hahn-Ast, C., Karthaus, M., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.019 · Cited by 91
Hammarström, H., Stjärne Aspelund, A., Christensson, B., Heußel, C. P., Isaksson, J., Kondori, N., Larsson, L., Markowicz, P., Richter, J., Wennerås, C., et al. (2018) · Mycoses · doi:10.1111/myc.12773 · Cited by 15
Metadata
- Authors
- Nucci, M., Garnica, M., Gloria, A. B., Lehugeur, D. S., Dias, V. C. H., Palma, L. C., Cappellano, P., Fertrin, K. Y., Carlesse, F., Simões, B., Bergamasco, M. D., Cunha, C. A., Seber, A., Ribeiro, M. P. D., Queiroz-Telles, F., Lee, M. L. M., Chauffaille, M. L., Silla, L., Souza, C. A. D., & Colombo, A. L.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 19
- Issue
- 8
- Pages
- 745-751
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2127402627
- Cited by
- 159
- References
- 29
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.